PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis - Contacts and Locations

PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

This study has been completed.

Study NCT00005005. Last updated on September 19, 2008. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005005

Locations


United States, Maine
	Maine Center for Osteoporosis
	Bangor, Maine, United States, 04401

United States, Minnesota
	University of Minnesota
	Minneapolis, Minnesota, United States, 55415

United States, New York
	Columbia University
	New York, New York, United States, 10032

United States, Pennsylvania
	University of Pittsburgh Medical Center
	Pittsburgh, Pennsylvania, United States, 15213

Sponsors and Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Investigators


Principal Investigator:	Dennis Black, PhD	University of California, San Francisco